S903-0155 Screening compound: 3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one

S903-0155 Screening compound: 3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one
S903-0155 Screening compound: 3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S903-0155
3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S903-0155

Molecular Formula

C19H27N5O3S2 (C19 H27 N5 O3 S2)

Compound Name

3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one

IUPAC name

3-methyl-1-{4-[7-(thiophene-2-sulfonyl)-5H6H7H8H-[124]triazolo[43-a]pyrazin-3-yl]piperidin-1-yl}butan-1-one

SMILES

CC(C)CC(N(CC1)CCC1c1nnc(C2)n1CCN2S(c1cccs1)(=O)=O)=O

InChI

InChI=1S/C19H27N5O3S2/c1-14(2)12-17(25)22-7-5-15(6-8-22)19-21-20-16-13-23(9-10-24(16)19)29(26,27)18-4-3-11-28-18/h3-4,11,14-15H,5-10,12-13H2,1-2H3

InChI Key

DTBIDUXAOMJULL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD31955910

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

437.59

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

1.498

Distribution Coefficient, logD

1.415

Water Solubility, LogSw

-2.35

Polar Surface Area

73.795

Acid Dissociation Constant (pKa)

21.04

Base Dissociation Constant (pKb)

6.72

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

63.16

S903-0155 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Autophagy-Targeted Library (4564 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Protein-Protein Interaction Library (218420 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Infections
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics
  • Cyclic compounds
  • Mimetics

References: we are preparing a list of scientific research reports with S903-0155 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S903-0155?
Check Price and Availability of S903-0155, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S903-0155 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S903-0155
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S903-0155
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S903-0155 available by request